New CBER Guidance, Posted 9 January 2002

Article

Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease (vCJD) by Blood and Blood Products

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.